Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

U.K. study reveals new potential marker of acute kidney injury in acute on chronic liver failure

April 30, 2012

Lucassin approved in Australia

April 26, 2012

Japan Tobacco and Torii report topline results from phase III GBA4-1 study

April 23, 2012

Tengion plans IND submission for Neo-Kidney Augment

April 19, 2012

Addex discloses encouraging data on lead oral small molecule

April 17, 2012

Research at Astellas yields novel phosphodiesterase 9A inhibitors

April 11, 2012

FDA advisory committee issues recommendation on Astellas' mirabegron

April 10, 2012

Astellas Pharma discloses new phosphodiesterase 9A inhibitors

April 5, 2012

AlloCure raises funds to support AC-607 development

April 4, 2012

Minirinmelt tablets approved in Japan

April 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...